Celastrol treatment in adult animals has also been reported to increase leptin sensitivity [13], ameliorate non-alcoholic fatty liver disease [14], and increase iWAT browning and BAT activation [41], which protect against diet-induced obesity. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.